GSK bone cancer treatment gets USFDA Breakthrough Therapy Designation Ruchika Sharma7 Jan 2025 3:00 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation for GSK5764227...
GSK Nucala approved in China for treatment of adults with chronic rhinosinusitis with nasal polyps Ruchika Sharma4 Jan 2025 1:00 PM ISTLondon: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a monoclonal antibody...
CDSCO Panel Approves GSK Protocol Amendment proposal for Belrestotug and Dostarlimab study Dr. Divya Colin27 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the drug major...
Jemperli bags USFDA Breakthrough Therapy Designation for locally advanced dMMR/MSI-H rectal cancer: GSK Ruchika Sharma16 Dec 2024 1:30 PM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Jemperli...
Blenrep combo accepted for priority review in China in relapsed/refractory multiple myeloma: GSK Ruchika Sharma11 Dec 2024 1:30 PM ISTLondon: GSK plc has announced that the National Medical Products Administration (NMPA) of China has accepted for review a new drug application...
USFDA accepts GSK submission for use of Nucala in COPD Ruchika Sharma11 Dec 2024 11:30 AM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review, data from the MATINEE study to support the...
Tafenoquine: WHO awards prequalification to single-dose medicine for P. vivax malaria Ruchika Sharma5 Dec 2024 12:30 PM ISTLondon: GSK plc and Medicines for Malaria Venture (MMV) has announced that the World Health Organization (WHO) has awarded prequalification to...
GSK fully liquid Menveo meningococcal vaccine approved by European Commission Ruchika Sharma29 Nov 2024 12:39 PM ISTLondon: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of...
USFDA accepts for review application for GSK Blenrep combinations for multiple myeloma treatment Ruchika Sharma26 Nov 2024 5:52 PM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for...
GSK's Augmentin Leads Indian Pharma Market in October with Rs 843 Crore Sales: Pharmatrac Report Farhat Nasim22 Nov 2024 5:40 PM ISTNew Delhi: As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the test of time...
GSK, Vesalius Therapeutics collaborate for novel treatments for Parkinson's disease Ruchika Sharma16 Nov 2024 12:35 PM ISTCambridge: Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, has...
GSK Ojjaara approved in Canada for treatment of myelofibrosis in adults who have moderate to severe anemia Ruchika Sharma14 Nov 2024 1:15 PM ISTMississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or...
